Announce Date | 12/31/1969 |
EPS Normalized Actual | $ In Line |
EPS GAAP Actual | $ In Line |
Revenue Actual | $13.713B |
Revenue Surprise | Beat by $13713M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0 | 0 | 13.713B | 6.19% | 13713M |
FQ3 2021 (Sep 2021) | 0 | 0 | 13.928B | 100% | 13928M |
FQ4 2020 (Dec 2020) | 0 | 0 | 12.864B | 20.52% | 12864M |
FQ4 2019 (Dec 2019) | 0 | 0 | 10.224B | 22.24% | 10224M |
FQ4 2018 (Dec 2018) | 0 | 0 | 7.95B | -12.74% | 7950M |
FQ4 2017 (Dec 2017) | 0 | 0 | 8.963B | 4.71% | 8963M |
FQ4 2016 (Dec 2016) | 0 | 0 | 8.541B | 14.75% | 8541M |
FQ4 2015 (Dec 2015) | 0 | 0 | 7.281B | -0.21% | 7281M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
0
EPS # of in-lines
8
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0 | 0 | NAN% | |
FQ3 2021 (Sep 2021) | 0 | 0 | NAN% | |
FQ4 2020 (Dec 2020) | 0 | 0 | NAN% | |
FQ4 2019 (Dec 2019) | 0 | 0 | NAN% | |
FQ4 2018 (Dec 2018) | 0 | 0 | NAN% | |
FQ4 2017 (Dec 2017) | 0 | 0 | NAN% | |
FQ4 2016 (Dec 2016) | 0 | 0 | NAN% | |
FQ4 2015 (Dec 2015) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2021 (Dec 2021) | $0B | $13.71B | $13713M | 100% |
FQ3 2021 (Sep 2021) | $0B | $13.93B | $13928M | 100% |
FQ4 2020 (Dec 2020) | $0B | $12.86B | $12864M | 100% |
FQ4 2019 (Dec 2019) | $0B | $10.22B | $10224M | 100% |
FQ4 2018 (Dec 2018) | $0B | $7.95B | $7950M | 100% |
FQ4 2017 (Dec 2017) | $0B | $8.96B | $8963M | 100% |
FQ4 2016 (Dec 2016) | $0B | $8.54B | $8541M | 100% |
FQ4 2015 (Dec 2015) | $0B | $7.28B | $7281M | 100% |